NCT01163747 - A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

tocilizumab

Intravenous repeating dose

DRUG

methotrexate

A stable dose of between 7.5 and 25 mg/week, oral or parenteral.

BIOLOGICAL

23-Valent Pneumococcal Polysaccharide Vaccine

Intramuscular or subcutaneous injection

BIOLOGICAL

Tetanus Toxoid Adsorbed Vaccine

Intramuscular injection

Trial Locations (47)

12206

Albany

15090

Wexford

16635

Duncansville

19152

Philadelphia

19610

Wyomissing

21224

Baltimore

21286

Baltimore

26301

Clarksburg

27834

Greenville

28012

Belmont

28210

Charlotte

29118

Orangeburg

29407

Charleston

32778

Tavares

32901

Melbourne

33143

South Miami

35294

Birmingham

35801

Huntsville

36207

Anniston

38801

Tupelo

44109

Cleveland

44130

Middleburg Heights

45631

Gallipolis

46601

South Bend

48080

Saint Clair Shores

60061

Vernon Hills

60153

Maywood

72401

Jonesboro

75150

Mesquite

75246

Dallas

83404

Idaho Falls

83702

Boise

85037

Paradise Valley

85202

Mesa

85253

Paradise Valley

85258

Scottsdale

85304

Glendale

89128

Las Vegas

91786

Upland

92543

Hemet

92835

Fullerton

93454

Santa Maria

94578

San Leandro

97035

Lake Oswego

98405

Tacoma

06606

Bridgeport

07726

Manalapan